Publication | Open Access
In Vitro Antimycobacterial Activities of 2′-Monosubstituted Isonicotinohydrazides and Their Cyanoborane Adducts
67
Citations
26
References
2002
Year
Pharmaceutical ScienceSodium CyanoborohydrideAntimicrobial ChemotherapyPharmaceutical ChemistryCyanoborane AdductsMedicinal ChemistryM. TuberculosisVitro Antimycobacterial ActivitiesAntimicrobial Drug DiscoveryTheir Cyanoborane AdductsBiochemistryTuberculosisAntibacterial AgentAntimicrobial CompoundPharmacology2′-Monosubstituted IsonicotinohydrazidesAntifungal AgentNatural SciencesAntimicrobial PharmacodynamicsMedicineDrug DiscoveryDrug Analysis
ABSTRACT As a result of our search for new isoniazid derivatives with extended spectra of activity, we evaluated the in vitro antimycobacterial activities of isonicotinohydrazides (compounds 2) and their cyanoborane adducts (compounds 3), both obtained by the reaction of isonicotinoylhydrazones (compounds 1) with sodium cyanoborohydride. Most of the tested compounds displayed moderate to high activity against Mycobacterium tuberculosis H37Rv, with MICs ranging from 0.2 to 12.5 μg/ml. In particular, some hydrazides showed activity similar to that of rifampin (MIC = 0.2 μg/ml) and rather low cytotoxicity, so that they were generally shown to possess high safety indices. In contrast, the coordination to a cyanoborane (BH 2 CN) group (compounds 3) in general brought about a decrease in antimycobacterial activity, while cytotoxicity increased. Interestingly, selected compounds 1 to 3, mostly hydrazides (compounds 2), were effective in killing M. tuberculosis growing within macrophages at concentrations in culture medium which were much lower than the corresponding MICs. These compounds also displayed good activity against drug-resistant M. tuberculosis strains.
| Year | Citations | |
|---|---|---|
Page 1
Page 1